Covid-19 Impact on Global Recombinant DNA (rDNA) Technology Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Recombinant DNA (rDNA) Technology Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
1.4 Covid-19 Implications on Market by Component
1.4.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Component: 2020 VS 2026
1.4.2 Expression System
1.4.3 Cloning Vector
1.5 Covid-19 Implications on Market by Application
1.5.1 Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology and Pharmaceutical Companies
1.5.3 Academic and Government Research Institutes
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant DNA (rDNA) Technology Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant DNA (rDNA) Technology Industry
1.6.1.1 Recombinant DNA (rDNA) Technology Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant DNA (rDNA) Technology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant DNA (rDNA) Technology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Growth Trends by Regions
2.2.1 Recombinant DNA (rDNA) Technology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Recombinant DNA (rDNA) Technology Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant DNA (rDNA) Technology Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Market Size
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2015-2020)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.2.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2019
3.3 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served
3.4 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
3.5 Date of Enter into Recombinant DNA (rDNA) Technology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Component (2015-2026)
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Component (2015-2020)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Component (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
6.2 Recombinant DNA (rDNA) Technology Key Players in North America (2019-2020)
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2015-2020)
7.2 Recombinant DNA (rDNA) Technology Key Players in Europe (2019-2020)
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
8 China
8.1 China Recombinant DNA (rDNA) Technology Market Size (2015-2020)
8.2 Recombinant DNA (rDNA) Technology Key Players in China (2019-2020)
8.3 China Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
8.4 China Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
9 Japan
9.1 Japan Recombinant DNA (rDNA) Technology Market Size (2015-2020)
9.2 Recombinant DNA (rDNA) Technology Key Players in Japan (2019-2020)
9.3 Japan Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
9.4 Japan Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Recombinant DNA (rDNA) Technology Market Size (2015-2020)
10.2 Recombinant DNA (rDNA) Technology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
11 India
11.1 India Recombinant DNA (rDNA) Technology Market Size (2015-2020)
11.2 Recombinant DNA (rDNA) Technology Key Players in India (2019-2020)
11.3 India Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
11.4 India Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
12.2 Recombinant DNA (rDNA) Technology Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
12.4 Central & South America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
13Key Players Profiles
13.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
13.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
13.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview and Its Total Revenue
13.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
13.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
13.2 Profacgen
13.2.1 Profacgen Company Details
13.2.2 Profacgen Business Overview and Its Total Revenue
13.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
13.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.2.5 Profacgen Recent Development
13.3 Amgen Inc
13.3.1 Amgen Inc Company Details
13.3.2 Amgen Inc Business Overview and Its Total Revenue
13.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
13.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.3.5 Amgen Inc Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
13.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 GenScript
13.5.1 GenScript Company Details
13.5.2 GenScript Business Overview and Its Total Revenue
13.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
13.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.5.5 GenScript Recent Development
13.6 Pfizer Inc
13.6.1 Pfizer Inc Company Details
13.6.2 Pfizer Inc Business Overview and Its Total Revenue
13.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
13.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.6.5 Pfizer Inc Recent Development
13.7 Novo Nordisk A/S
13.7.1 Novo Nordisk A/S Company Details
13.7.2 Novo Nordisk A/S Business Overview and Its Total Revenue
13.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
13.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.7.5 Novo Nordisk A/S Recent Development
13.8 Eli Lilly and Company
13.8.1 Eli Lilly and Company Company Details
13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
13.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.8.5 Eli Lilly and Company Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview and Its Total Revenue
13.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
13.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.9.5 Sanofi Recent Development
13.10 Biocon
13.10.1 Biocon Company Details
13.10.2 Biocon Business Overview and Its Total Revenue
13.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
13.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
13.10.5 Biocon Recent Development
13.11 GlaxoSmithKline plc
10.11.1 GlaxoSmithKline plc Company Details
10.11.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
10.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
10.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.11.5 GlaxoSmithKline plc Recent Development
13.12 New England Biolabs.
10.12.1 New England Biolabs. Company Details
10.12.2 New England Biolabs. Business Overview and Its Total Revenue
10.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
10.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.12.5 New England Biolabs. Recent Development
13.13 Cibus
10.13.1 Cibus Company Details
10.13.2 Cibus Business Overview and Its Total Revenue
10.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
10.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.13.5 Cibus Recent Development
13.14 Monsanto Company
10.14.1 Monsanto Company Company Details
10.14.2 Monsanto Company Business Overview and Its Total Revenue
10.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
10.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.14.5 Monsanto Company Recent Development
13.15 Horizon Discovery Group PLC
10.15.1 Horizon Discovery Group PLC Company Details
10.15.2 Horizon Discovery Group PLC Business Overview and Its Total Revenue
10.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
10.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
10.15.5 Horizon Discovery Group PLC Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Recombinant DNA (rDNA) Technology Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
Table 3. Ranking of Global Top Recombinant DNA (rDNA) Technology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Component (US$ Million): 2020 VS 2026
Table 5. Key Players of Expression System
Table 6. Key Players of Cloning Vector
Table 7. COVID-19 Impact Global Market: (Four Recombinant DNA (rDNA) Technology Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Recombinant DNA (rDNA) Technology Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Recombinant DNA (rDNA) Technology Players to Combat Covid-19 Impact
Table 12. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Recombinant DNA (rDNA) Technology Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Recombinant DNA (rDNA) Technology Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2015-2020)
Table 16. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Recombinant DNA (rDNA) Technology Market Growth Strategy
Table 22. Main Points Interviewed from Key Recombinant DNA (rDNA) Technology Players
Table 23. Global Recombinant DNA (rDNA) Technology Revenue by Players (2015-2020) (Million US$)
Table 24. Global Recombinant DNA (rDNA) Technology Market Share by Players (2015-2020)
Table 25. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2019)
Table 26. Global Recombinant DNA (rDNA) Technology by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
Table 29. Date of Enter into Recombinant DNA (rDNA) Technology Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 32. Global Recombinant DNA (rDNA) Technology Market Size Share by Component (2015-2020)
Table 33. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Component (2021-2026)
Table 34. Global Recombinant DNA (rDNA) Technology Market Size Share by Application (2015-2020)
Table 35. Global Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 36. Global Recombinant DNA (rDNA) Technology Market Size Share by Application (2021-2026)
Table 37. North America Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 39. North America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 40. North America Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 41. North America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 42. North America Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 43. Europe Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 45. Europe Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 46. Europe Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 47. Europe Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 49. China Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 50. China Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 51. China Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 52. China Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 53. China Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 54. China Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 55. Japan Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 57. Japan Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 58. Japan Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 59. Japan Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 63. Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 64. Southeast Asia Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 65. Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 67. India Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 68. India Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 69. India Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 70. India Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 71. India Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 72. India Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Recombinant DNA (rDNA) Technology Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Recombinant DNA (rDNA) Technology Market Share (2019-2020)
Table 75. Central & South America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020) (Million US$)
Table 76. Central & South America Recombinant DNA (rDNA) Technology Market Share by Component (2015-2020)
Table 77. Central & South America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Recombinant DNA (rDNA) Technology Market Share by Application (2015-2020)
Table 79. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
Table 80. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
Table 81. F. Hoffmann-La Roche Ltd (Genentech, Inc) Product
Table 82. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 83. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
Table 84. Profacgen Company Details
Table 85. Profacgen Business Overview
Table 86. Profacgen Product
Table 87. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 88. Profacgen Recent Development
Table 89. Amgen Inc Company Details
Table 90. Amgen Inc Business Overview
Table 91. Amgen Inc Product
Table 92. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 93. Amgen Inc Recent Development
Table 94. Novartis AG Company Details
Table 95. Novartis AG Business Overview
Table 96. Novartis AG Product
Table 97. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 98. Novartis AG Recent Development
Table 99. GenScript Company Details
Table 100. GenScript Business Overview
Table 101. GenScript Product
Table 102. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 103. GenScript Recent Development
Table 104. Pfizer Inc Company Details
Table 105. Pfizer Inc Business Overview
Table 106. Pfizer Inc Product
Table 107. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 108. Pfizer Inc Recent Development
Table 109. Novo Nordisk A/S Company Details
Table 110. Novo Nordisk A/S Business Overview
Table 111. Novo Nordisk A/S Product
Table 112. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 113. Novo Nordisk A/S Recent Development
Table 114. Eli Lilly and Company Business Overview
Table 115. Eli Lilly and Company Product
Table 116. Eli Lilly and Company Company Details
Table 117. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 118. Eli Lilly and Company Recent Development
Table 119. Sanofi Company Details
Table 120. Sanofi Business Overview
Table 121. Sanofi Product
Table 122. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 123. Sanofi Recent Development
Table 124. Biocon Company Details
Table 125. Biocon Business Overview
Table 126. Biocon Product
Table 127. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 128. Biocon Recent Development
Table 129. GlaxoSmithKline plc Company Details
Table 130. GlaxoSmithKline plc Business Overview
Table 131. GlaxoSmithKline plc Product
Table 132. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 133. GlaxoSmithKline plc Recent Development
Table 134. New England Biolabs. Company Details
Table 135. New England Biolabs. Business Overview
Table 136. New England Biolabs. Product
Table 137. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 138. New England Biolabs. Recent Development
Table 139. Cibus Company Details
Table 140. Cibus Business Overview
Table 141. Cibus Product
Table 142. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 143. Cibus Recent Development
Table 144. Monsanto Company Company Details
Table 145. Monsanto Company Business Overview
Table 146. Monsanto Company Product
Table 147. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 148. Monsanto Company Recent Development
Table 149. Horizon Discovery Group PLC Company Details
Table 150. Horizon Discovery Group PLC Business Overview
Table 151. Horizon Discovery Group PLC Product
Table 152. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020) (Million US$)
Table 153. Horizon Discovery Group PLC Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA (rDNA) Technology Market Share by Component: 2020 VS 2026
Figure 2. Expression System Features
Figure 3. Cloning Vector Features
Figure 4. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2026
Figure 5. Biotechnology and Pharmaceutical Companies Case Studies
Figure 6. Academic and Government Research Institutes Case Studies
Figure 7. Other Case Studies
Figure 8. Recombinant DNA (rDNA) Technology Report Years Considered
Figure 9. Global Recombinant DNA (rDNA) Technology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Recombinant DNA (rDNA) Technology Market Share by Regions: 2020 VS 2026
Figure 11. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2019
Figure 14. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2019
Figure 16. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. F. Hoffmann-La Roche Ltd (Genentech, Inc) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 25. Profacgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 27. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 29. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 31. GenScript Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 33. Pfizer Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 35. Novo Nordisk A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 37. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 41. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 43. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. GlaxoSmithKline plc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 45. New England Biolabs. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. New England Biolabs. Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 47. Cibus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Cibus Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 49. Monsanto Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Monsanto Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 51. Horizon Discovery Group PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Horizon Discovery Group PLC Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs